Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA
New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )
27 Apr 2016

AML17 Trial results: maximum dosage of daunorubicin in AML

Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK
AML17 Trial results: maximum dosage of daunorubicin in AML ( Dr Mike Dennis - Christie Hospital NHS Foundation Trust, Manchester, UK )
27 Apr 2016

AML during pregancy

Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK
AML during pregancy ( Dr Sahra Ali - Hull and East Yorkshire Hospitals NHS Trust, Hull, UK )
27 Apr 2016

Germ line predisposition to leukaemia

Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA
Germ line predisposition to leukaemia ( Dr Kevin Shannon - UCSF Helen Diller, San Francisco, USA )
27 Apr 2016

The future of haematopathology

Prof Alberto Zamo - University of Verona, Verona, Italy
The future of haematopathology ( Prof Alberto Zamo - University of Verona, Verona, Italy )
27 Apr 2016

Frontline therapy in young patients with myeloma

Prof Philippe Moreau - University of Nantes, Nantes, France
Frontline therapy in young patients with myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
27 Apr 2016

Genomics of childhood ALL

Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel
Genomics of childhood ALL ( Prof Shai Izraeli - Sheba Medical Centre, Ramat Gan, Israel )
27 Apr 2016

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA
Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )
27 Apr 2016

New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations ( Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia )
27 Apr 2016

MINDACT breast cancer clinical trial: First results and impact on future trial design

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Apr 2016

Breast cancer research news from AACR President Nancy Davidson

Dr Nancy Davidson - AACR President, Philadelphia, USA
Breast cancer research news from AACR President Nancy Davidson ( Dr Nancy Davidson - AACR President, Philadelphia, USA )
27 Apr 2016

Non-coding mutations driving chronic lymphocytic leukaemia

Dr Xose Puente - University of Oviedo, Oviedo, Spain
Non-coding mutations driving chronic lymphocytic leukaemia ( Dr Xose Puente - University of Oviedo, Oviedo, Spain )
27 Apr 2016